Hydrix is pursuing a strategy of “buy, build, invest”
Hydrix is pursuing three distinct business growth strategies:
Buy: We are seeking, and regularly assessing, strategic target companies for acquisition.
Build: We are always keen to build out and commercialize IP. We are currently developing and maturing a MEMS-based P4 spectrometer, which remains on track for prototype release in 2019/2020.
Invest: We partner with, and incubate, start-up companies at our Melbourne office. We have dedicated office space and laboratories currently utilized by a number of clients. We have also established a primary material investment in Gyder Surgical through a collaborative partnership, and continue to seek further investment opportunities across our strategic markets.